To determine which cell death pathway was activated in IR-treated NPC cells, we utilized three inhibitors, including z-VAD-fmk, necrostatin-1 (Nec-1), and 3-MA, to pretreat NPC cells. The gene discussed is PCSK1; the disease is nasopharyngeal carcinoma.